Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Biochemical and Biological Attributes of Matrix Metalloproteinases.

Cui N, Hu M, Khalil RA.

Prog Mol Biol Transl Sci. 2017;147:1-73. doi: 10.1016/bs.pmbts.2017.02.005. Epub 2017 Mar 22. Review.

2.

Identification and initial characterization of matrix metalloproteinases in the yellow fever mosquito, Aedes aegypti.

Kantor AM, Dong S, Held NL, Ishimwe E, Passarelli AL, Clem RJ, Franz AW.

Insect Mol Biol. 2017 Feb;26(1):113-126. doi: 10.1111/imb.12275. Epub 2016 Nov 7.

3.

Evidence for a Proapoptotic Role of Matrix Metalloproteinase-26 in Human Prostate Cancer Cells and Tissues.

Khamis ZI, Iczkowski KA, Man YG, Bou-Dargham MJ, Sang QX.

J Cancer. 2016 Jan 1;7(1):80-7. doi: 10.7150/jca.13067. eCollection 2016.

4.

The significance of matrix metalloproteinases in parasitic infections involving the central nervous system.

Bruschi F, Pinto B.

Pathogens. 2013 Feb 19;2(1):105-29. doi: 10.3390/pathogens2010105. Review.

5.

Citrate synthase is a novel in vivo matrix metalloproteinase-9 substrate that regulates mitochondrial function in the postmyocardial infarction left ventricle.

de Castro Brás LE, Cates CA, DeLeon-Pennell KY, Ma Y, Iyer RP, Halade GV, Yabluchanskiy A, Fields GB, Weintraub ST, Lindsey ML.

Antioxid Redox Signal. 2014 Nov 10;21(14):1974-85. doi: 10.1089/ars.2013.5411. Epub 2014 Feb 19.

6.

Matrix metalloproteinase-9: Many shades of function in cardiovascular disease.

Yabluchanskiy A, Ma Y, Iyer RP, Hall ME, Lindsey ML.

Physiology (Bethesda). 2013 Nov;28(6):391-403. doi: 10.1152/physiol.00029.2013. Review.

7.

Recombinant TIMP-1-GPI inhibits growth of fibrosarcoma and enhances tumor sensitivity to doxorubicin.

Bao Q, Niess H, Djafarzadeh R, Zhao Y, Schwarz B, Angele MK, Jauch KW, Nelson PJ, Bruns CJ.

Target Oncol. 2014 Sep;9(3):251-61. doi: 10.1007/s11523-013-0294-5. Epub 2013 Aug 10.

8.

GM-CSF enhances tumor invasion by elevated MMP-2, -9, and -26 expression.

Gutschalk CM, Yanamandra AK, Linde N, Meides A, Depner S, Mueller MM.

Cancer Med. 2013 Apr;2(2):117-29. doi: 10.1002/cam4.20. Epub 2012 Nov 26.

9.

The Anti-inflammatory Role of Endometase/Matrilysin-2 in Human Prostate Cancer Cells.

Khamis ZI, Zorio DA, Chung LW, Sang QX.

J Cancer. 2013;4(4):296-303. doi: 10.7150/jca.5788. Epub 2013 Mar 20.

10.

Matrix metalloproteinases as potential targets in the venous dilation associated with varicose veins.

Kucukguven A, Khalil RA.

Curr Drug Targets. 2013 Mar;14(3):287-324. Review.

11.

Localization and hormonal regulation of endometrial matrix metalloproteinase-26 in the rhesus macaque.

Almeida-Francia CC, Keator CS, Mah K, Holden L, Hergert C, Slayden OD.

Hum Reprod. 2012 Jun;27(6):1723-34. doi: 10.1093/humrep/des086. Epub 2012 Mar 20.

12.
14.

Nitroglycerin alters matrix remodeling proteins in THP-1 human macrophages and plasma metalloproteinase activity in rats.

Krishnatry AS, Fung SM, Brazeau DA, Soda D, Fung HL.

Nitric Oxide. 2011 Mar 15;24(2):66-76. doi: 10.1016/j.niox.2010.12.002. Epub 2010 Dec 13.

15.

Physiology and pathophysiology of matrix metalloproteases.

Klein T, Bischoff R.

Amino Acids. 2011 Jul;41(2):271-90. doi: 10.1007/s00726-010-0689-x. Epub 2010 Jul 18. Review.

16.

GnRH I and II up-regulate MMP-26 expression through the JNK pathway in human cytotrophoblasts.

Liu J, Cao B, Li YX, Wu XQ, Wang YL.

Reprod Biol Endocrinol. 2010 Jan 15;8:5. doi: 10.1186/1477-7827-8-5.

18.

A genomic analysis of rat proteases and protease inhibitors.

Puente XS, López-Otín C.

Genome Res. 2004 Apr;14(4):609-22.

20.

Supplemental Content

Support Center